Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel

BACKGROUND: Morbidity due to schistosomiasis is currently controlled by treatment of schistosome infected people with the antihelminthic drug praziquantel (PZQ). Children aged up to 5 years are currently excluded from schistosome control programmes largely due to the lack of PZQ safety data in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutapi, Francisca, Rujeni, Nadine, Bourke, Claire, Mitchell, Kate, Appleby, Laura, Nausch, Norman, Midzi, Nicholas, Mduluza, Takafira
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096601/
https://www.ncbi.nlm.nih.gov/pubmed/21610855
http://dx.doi.org/10.1371/journal.pntd.0001143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096601/
https://www.ncbi.nlm.nih.gov/pubmed/21610855
http://dx.doi.org/10.1371/journal.pntd.0001143

Ejemplares similares